Search research articles
Contact Us
Filters
Showing results (121-130 of 134) with videos related to
Page
of 14
Sort By:
ESMO Open
|
August 3, 2022
Position paper of the Italian Association of Medical Oncology on the impact of COVID-19 on Italian oncology and the path forward: the 2021 Matera statement
G D Beretta, R Casolino, D C Corsi, et al.
Mutation Research
|
April 1, 1976
Evaluation of the genetic effects induced by vinyl chloride monomer (VCM) under mammalian metabolic activation: studies in vitro and in vivo
N Loprieno, R Barale, S Baroncelli, et al.
Mutation Research
|
August 1, 1975
Proceedings: The use of yeast genetic systems in environmental mutagenesis
N Loprieno, R Barale, S Baroncelli, et al.
Mutation Research
|
November 1, 1976
Mutagenicity of industrial compounds: styrene and its possible metabolite styrene oxide
N Loprieno, A Abbondandolo, R Barale, et al.
Oncogene
|
February 14, 2007
Gene expression analysis of early and advanced gastric cancers
M Vecchi, P Nuciforo, S Romagnoli, et al.
Clinical Colorectal Cancer
|
July 5, 2024
Chemotherapy Rechallenge or Reintroduction Compared to Regorafenib or Trifluridine/Tipiracil for Pretreated Metastatic Colorectal Cancer Patients: A Propensity Score Analysis of Treatment Beyond Second Line (Proserpyna Study)
M A Calegari, I V Zurlo, E Dell'Aquila, et al.
Journal of Translational Medicine
|
February 16, 2021
Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access program
Giovanni Grignani, Vanna Chiarion Sileni, Carmine Pinto, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2017
Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patients
Stefano Cascinu, Gerardo Rosati, Guglielmo Nasti, et al.
JAMA Oncology
|
November 27, 2018
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial
Chiara Cremolini, Daniele Rossini, Emanuela Dell'Aquila, et al.
Drug Development Research
|
January 29, 2024
Purinoceptors in the Central Nervous System
T V Dunwiddie, M P Abbracchio, N Bischofberger, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 134) with videos related to
Sort By:
Page
of 14
ESMO Open
|
August 3, 2022
Position paper of the Italian Association of Medical Oncology on the impact of COVID-19 on Italian oncology and the path forward: the 2021 Matera statement
G D Beretta, R Casolino, D C Corsi, et al.
Mutation Research
|
April 1, 1976
Evaluation of the genetic effects induced by vinyl chloride monomer (VCM) under mammalian metabolic activation: studies in vitro and in vivo
N Loprieno, R Barale, S Baroncelli, et al.
Mutation Research
|
August 1, 1975
Proceedings: The use of yeast genetic systems in environmental mutagenesis
N Loprieno, R Barale, S Baroncelli, et al.
Mutation Research
|
November 1, 1976
Mutagenicity of industrial compounds: styrene and its possible metabolite styrene oxide
N Loprieno, A Abbondandolo, R Barale, et al.
Oncogene
|
February 14, 2007
Gene expression analysis of early and advanced gastric cancers
M Vecchi, P Nuciforo, S Romagnoli, et al.
Clinical Colorectal Cancer
|
July 5, 2024
Chemotherapy Rechallenge or Reintroduction Compared to Regorafenib or Trifluridine/Tipiracil for Pretreated Metastatic Colorectal Cancer Patients: A Propensity Score Analysis of Treatment Beyond Second Line (Proserpyna Study)
M A Calegari, I V Zurlo, E Dell'Aquila, et al.
Journal of Translational Medicine
|
February 16, 2021
Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access program
Giovanni Grignani, Vanna Chiarion Sileni, Carmine Pinto, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2017
Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patients
Stefano Cascinu, Gerardo Rosati, Guglielmo Nasti, et al.
JAMA Oncology
|
November 27, 2018
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial
Chiara Cremolini, Daniele Rossini, Emanuela Dell'Aquila, et al.
Drug Development Research
|
January 29, 2024
Purinoceptors in the Central Nervous System
T V Dunwiddie, M P Abbracchio, N Bischofberger, et al.
Page
of 14